Related Experiment Video
Updated: Jan 7, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
RPL41 inhibits the proliferation and migration of retinoblastoma through the ARL5B-associated lysosomal trafficking
Ye Li1, Tian Zhan1, Tianfu Chen1
1Department of Ophthalmology, Shengjing Hospital of China Medical University, Shengyang, Liaoning, China.
Purpose:
Retinoblastoma is the most common intraocular cancer in infants and children, with a significant potential for metastasis. The mini-peptide ribosomal protein L41 (RPL41) has demonstrated extensive antitumor effects in vitro by promoting the degradation of activating transcription factor 4 (ATF4). This study aims to evaluate the therapeutic effect of RPL41 on retinoblastoma and elucidate its potential mechanisms.
Methods:
A xenografted retinoblastoma model was constructed in nude mice. The effects of xenografted RPL41 on tumor proliferation, invasion and metastasis were evaluated by local injection. Mass spectrometry identified differentially expressed genes in Y79 and Weri-RB1 retinoblastoma cells pre- and post-treatment. We utilized quantitative real-time PCR (qRT-PCR), Western blotting, and immunohistochemistry to assess the expression levels of ARL5B(ADP ribosylation factor like GTPase 5B) in retinoblastoma cell lines and tissues. We also explored ATF4's regulatory role on ARL5B expression through chromatin immunoprecipitation (ChIP) experiments and luciferase reporter gene assays.
Results:
RPL41 inhibits the growth of subcutaneous retinoblastoma xenografts. ARL5B expression was significantly downregulated in treated Y79 and Weri-RB1 cells. ARL5B was upregulated in retinoblastoma cells and clinicopathological tissues. RPL41 treatment led to ATF4 degradation, reducing the expression levels of ARL5B and lysotransfer-related molecules. Knocking down ATF4 decreased ARL5B protein levels. ChIP experiments and dual-luciferase assays confirmed ATF4 positively regulates ARL5B. Rescue experiments indicated that ARL5B overexpression partially reversed the effects of RPL41 therapy or ATF4 knockdown on lysosomal pathways and cell migration.
Conclusions:
RPL41 down-regulates the expression of ARL5B by degrading ATF4 and the impaired ARL5B-related lysosomal trafficking is a mechanism to inhibit the metastasis of retinoblastoma.
Insights
Ribosomal protein L41 (RPL41) inhibits retinoblastoma growth and metastasis by degrading ATF4, which downregulates ARL5B and impairs lysosomal trafficking. This novel mechanism offers a potential therapeutic strategy for retinoblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Retinoblastoma is a common pediatric intraocular cancer with high metastatic potential.
- Ribosomal protein L41 (RPL41) exhibits in vitro antitumor activity by promoting ATF4 degradation.
Purpose of the Study:
- To evaluate the therapeutic efficacy of RPL41 in retinoblastoma.
- To elucidate the underlying molecular mechanisms of RPL41's action, focusing on ATF4 and ARL5B.
Main Methods:
- Construction of a xenografted retinoblastoma mouse model for in vivo evaluation.
- Utilized mass spectrometry, qRT-PCR, Western blotting, and immunohistochemistry to assess gene and protein expression.
- Employed chromatin immunoprecipitation (ChIP) and luciferase reporter assays to investigate ATF4-ARL5B interactions.
Main Results:
- RPL41 inhibited retinoblastoma xenograft growth and reduced ARL5B expression in retinoblastoma cells.
- ARL5B was found to be upregulated in retinoblastoma tissues.
- RPL41 treatment led to ATF4 degradation, subsequently decreasing ARL5B and lysotransfer-related molecule levels, with ATF4 positively regulating ARL5B.
Conclusions:
- RPL41 downregulates ARL5B expression via ATF4 degradation.
- Impaired ARL5B-related lysosomal trafficking is a key mechanism by which RPL41 inhibits retinoblastoma metastasis.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Abnormal Proliferation
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

